How should a patient with a one-month history of fever and cough be evaluated and managed for suspected cryptococcosis?

Evaluation and Management of Suspected Cryptococcosis with One-Month Fever and Cough

For a patient with one month of fever and cough concerning for cryptococcosis, immediately perform HIV testing, serum cryptococcal antigen, chest CT, and lumbar puncture to rule out CNS involvement—then initiate treatment based on disease extent and immune status. 1

Initial Diagnostic Workup

The prolonged symptom duration (one month) demands urgent evaluation for disseminated disease, as cryptococcosis frequently involves multiple organ systems even when respiratory symptoms predominate.

Essential First Steps:

• HIV testing: All patients with suspected cryptococcosis must be tested for HIV, as this fundamentally alters management 1
• Serum cryptococcal antigen: Highly sensitive screening test
• Chest CT: Assess pulmonary involvement pattern (nodules, masses, consolidation, cavitation) 2
• Blood cultures: For cryptococcemia detection
• Lumbar puncture with opening pressure measurement: Critical even in asymptomatic patients, as CNS involvement occurs in approximately 18% of pulmonary cases and dramatically changes treatment intensity and duration 1, 2

Key Clinical Pitfall:

Do not assume isolated pulmonary disease based on respiratory symptoms alone. The one-month duration suggests either delayed presentation or inadequate initial evaluation. CNS involvement can be asymptomatic initially, and missing meningitis leads to inadequate treatment and poor outcomes 1, 3.

Treatment Algorithm Based on Findings

If CNS Involvement Confirmed (Meningitis):

HIV-Positive Patients:

• Induction (2 weeks): Amphotericin B deoxycholate (0.7-1.0 mg/kg/day IV) PLUS flucytosine (100 mg/kg/day divided in 4 doses) 1
• Consolidation (8 weeks): Fluconazole 400 mg daily
• Maintenance (≥1 year): Fluconazole 200 mg daily until CD4 >100 cells/μL for ≥3 months on HAART 1
• Start HAART 2-10 weeks after antifungal initiation to reduce IRIS risk 1

Transplant/Immunosuppressed Patients:

• Induction (≥2 weeks): Liposomal amphotericin B (3-4 mg/kg/day) or ABLC (5 mg/kg/day) PLUS flucytosine (100 mg/kg/day) 1
• Avoid amphotericin B deoxycholate due to nephrotoxicity risk in this population 1
• Consolidation (8 weeks): Fluconazole 400-800 mg daily
• Maintenance (6-12 months): Fluconazole 200-400 mg daily 1

If Pulmonary Disease WITHOUT CNS Involvement:

Immunosuppressed Patients (HIV, transplant, chronic steroids):

• Mild-to-moderate symptoms, no diffuse infiltrates: Fluconazole 400 mg daily for 6-12 months 1
• Severe pneumonia or ARDS: Treat as CNS disease with amphotericin B-based induction therapy 1

Immunocompetent Patients:

• Mild-to-moderate symptoms: Fluconazole 400 mg daily for 6-12 months 1
• Severe disease: Treat as CNS disease 1
• Asymptomatic nodule with negative/very low serum antigen: Lumbar puncture can be avoided, but close monitoring required 1

If Disseminated Disease (≥2 noncontiguous sites or cryptococcal antigen ≥1:512):

Treat as CNS disease regardless of meningitis presence 1

Critical Management Principles

Intracranial Pressure Monitoring:

Aggressively manage elevated ICP with serial lumbar punctures to maintain opening pressure <20 cm H₂O. This is the most important intervention for preventing mortality in cryptococcal meningitis 1. Consider VP shunt if persistently elevated despite frequent drainage 1.

IRIS Recognition:

Distinguish treatment failure from immune reconstitution inflammatory syndrome (IRIS), which can occur 2-10 weeks after starting HAART or reducing immunosuppression 1. IRIS presents with worsening symptoms despite negative cultures and may require corticosteroids (prednisone 0.5-1.0 mg/kg/day for 2-6 weeks) for severe CNS manifestations 1.

Immunosuppression Adjustment:

In transplant recipients, sequentially reduce immunosuppressants, lowering corticosteroids first 1.

Common Diagnostic Pitfalls to Avoid

1. Assuming isolated pulmonary disease: Always perform lumbar puncture in immunosuppressed patients 1
2. Misinterpreting imaging as malignancy: Cryptococcal nodules/masses can mimic lung cancer with brain metastases 4, 5
3. Inadequate treatment duration: One month of symptoms suggests established infection requiring full induction-consolidation-maintenance sequence
4. Ignoring opening pressure: Failure to measure and manage ICP is associated with increased mortality 1
5. Premature discontinuation: Persistently positive serum antigen alone is NOT an indication to continue therapy in non-CNS disease 1

The one-month symptom duration in this case suggests either delayed presentation or possible treatment failure if antibiotics were already attempted. Urgent comprehensive evaluation is mandatory to prevent progression to disseminated disease or death.